Figure 3

The HER2 positivity and overall survival of the 80 patients. Kaplan-Meier survival curve according to the HER2 positivity assessed by (a) IHC and/or SISH (P = 0.700), (b) tissue ddPCR (P = 0.146), and (c) plasma ddPCR (P = 0.381).
The HER2 positivity and overall survival of the 80 patients. Kaplan-Meier survival curve according to the HER2 positivity assessed by (a) IHC and/or SISH (P = 0.700), (b) tissue ddPCR (P = 0.146), and (c) plasma ddPCR (P = 0.381).